Dottikon Es is a company based in Switzerland that manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the chemical, biotech, and pharmaceutical industries. Specialized in hazardous reactions, the company positions itself as a strategic development and manufacturing partner with a focus on safety culture. With over 110 years of experience, Dottikon Es innovatively utilizes hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing to challenge conventional chemical synthesis routes and improve environmental sustainability. The company's one-site strategy allows for reduced decision and communication pathways, ensuring rapid and efficient project development and clear customer communication. Dating back to 1913, the company operates in the manufacturing and pharmaceutical industries, with its headquarters in Switzerland. Currently, there is no available information on their last investment or the investors involved.
There is no investment information
No recent news or press coverage available for Dottikon Exclusive Synthesis AG.